TIAA CREF Investment Management LLC Sells 9,020 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

TIAA CREF Investment Management LLC decreased its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 10.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,620 shares of the company’s stock after selling 9,020 shares during the period. TIAA CREF Investment Management LLC’s holdings in U.S. Physical Therapy were worth $5,330,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in USPH. Aberdeen Asset Management PLC UK increased its position in U.S. Physical Therapy by 11.0% in the first quarter. Aberdeen Asset Management PLC UK now owns 621,754 shares of the company’s stock worth $40,601,000 after buying an additional 61,715 shares during the period. Dimensional Fund Advisors LP increased its position in U.S. Physical Therapy by 1.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 478,561 shares of the company’s stock worth $33,595,000 after buying an additional 7,606 shares during the period. State Street Corp increased its position in U.S. Physical Therapy by 10.2% in the fourth quarter. State Street Corp now owns 297,114 shares of the company’s stock worth $20,851,000 after buying an additional 27,511 shares during the period. Principal Financial Group Inc. increased its position in U.S. Physical Therapy by 3.8% in the first quarter. Principal Financial Group Inc. now owns 100,739 shares of the company’s stock worth $6,578,000 after buying an additional 3,670 shares during the period. Finally, Legato Capital Management LLC increased its position in U.S. Physical Therapy by 6,430.0% in the first quarter. Legato Capital Management LLC now owns 95,534 shares of the company’s stock worth $1,463,000 after buying an additional 94,071 shares during the period. Institutional investors and hedge funds own 96.89% of the company’s stock.

U.S. Physical Therapy, Inc. (NYSE USPH) opened at 61.85 on Wednesday. The company has a market cap of $777.95 million, a PE ratio of 37.26 and a beta of 1.06. The firm’s 50 day moving average is $62.95 and its 200 day moving average is $66.96. U.S. Physical Therapy, Inc. has a 52-week low of $51.96 and a 52-week high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, June 29th. The company reported $0.51 EPS for the quarter, beating the Zacks’ consensus estimate of $0.49 by $0.02. U.S. Physical Therapy had a net margin of 6.44% and a return on equity of 12.44%. The firm had revenue of $97.57 million for the quarter, compared to analysts’ expectations of $97.60 million. Analysts forecast that U.S. Physical Therapy, Inc. will post $2.14 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, July 7th. Stockholders of record on Friday, June 16th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date of this dividend was Wednesday, June 14th. U.S. Physical Therapy’s payout ratio is 42.33%.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by [[site]] and is the property of of [[site]]. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at [[permalink]].

USPH has been the subject of a number of analyst reports. Zacks Investment Research downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Wednesday, June 21st. Barrington Research upgraded U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price target for the company in a research note on Monday, July 3rd. Finally, Jefferies Group LLC reissued a “hold” rating and set a $63.00 target price on shares of U.S. Physical Therapy in a research report on Friday, June 30th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. U.S. Physical Therapy currently has an average rating of “Hold” and an average price target of $66.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).